Detalhe da pesquisa
1.
Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials.
Lancet
; 399(10328): 909-923, 2022 03 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35248186
2.
Demographic, clinical, and patient-reported outcome data from 2 global, phase 3 trials of chronic cough.
Ann Allergy Asthma Immunol
; 130(1): 60-66, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35569802
3.
Efficacy and Safety of Eliapixant in Refractory Chronic Cough: The Randomized, Placebo-Controlled Phase 2b PAGANINI Study.
Lung
; 201(3): 255-266, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37261531
4.
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 2b Trial of P2X3 Receptor Antagonist Sivopixant for Refractory or Unexplained Chronic Cough.
Lung
; 201(1): 25-35, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36512069
5.
Evidence for Alpha7 Nicotinic Receptor Activation During the Cough Suppressing Effects Induced by Nicotine and Identification of ATA-101 as a Potential Novel Therapy for the Treatment of Chronic Cough.
J Pharmacol Exp Ther
; 380(2): 94-103, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34782407
6.
Long-Term Follow up of Renal and Other Acute Organ Failure in Survivors of Critical Illness Due to Covid-19.
J Intensive Care Med
; 37(6): 736-742, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34918990
7.
Improvements in Objective and Subjective Measures of Chronic Cough with Gefapixant: A Pooled Phase 3 Efficacy Analysis of Predefined Subgroups.
Lung
; 200(4): 423-429, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35895098
8.
COVID-19-Associated Critical Illness-Report of the First 300 Patients Admitted to Intensive Care Units at a New York City Medical Center.
J Intensive Care Med
; 35(10): 963-970, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32812834
9.
P2X3-Receptor Antagonists as Potential Antitussives: Summary of Current Clinical Trials in Chronic Cough.
Lung
; 198(4): 609-616, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32661659
10.
Vaping-Associated Acute Respiratory Failure Due to Acute Lipoid Pneumonia.
Lung
; 198(1): 31-33, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31583455
11.
Diabetes Insipidus After Discontinuation of Vasopressin Infusion for Treatment of Shock.
Crit Care Med
; 47(12): e1008-e1013, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31567344
12.
Prevalence of Arnold nerve reflex in subjects with and without chronic cough: Relevance to Cough Hypersensitivity Syndrome.
Pulm Pharmacol Ther
; 54: 22-24, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30445192
13.
Antitussive therapy: A role for levodropropizine.
Pulm Pharmacol Ther
; 56: 79-85, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30872161
14.
LUNG Year in Review: 2023.
Lung
; 202(1): 1-4, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38305892
15.
Reply to Weinberger.
Am J Respir Crit Care Med
; 207(12): 1650-1651, 2023 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37104844
16.
Efficacy and Safety of Gefapixant for Refractory or Unexplained Chronic Cough over 52 Weeks.
Am J Respir Crit Care Med
; 207(11): 1539-1542, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36996347
17.
LUNG Year in Review: 2022.
Lung
; 201(1): 1-4, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36717405
18.
Effect of tobacco and electronic cigarette use on cough reflex sensitivity.
Pulm Pharmacol Ther
; 47: 45-48, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28185897
19.
LUNG Year in Review: 2021.
Lung
; 200(1): 1-4, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35041063
20.
Tackling the Neuropathic Cough of Idiopathic Pulmonary Fibrosis (IPF): More Needs to be Done.
Lung
; 200(6): 673-675, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36348052